Ralph Niven - CHIEF SCIENTIFIC OFFICER at Aerovate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
AVTE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ralph Niven - trading volume in the past year for Aerovate Therapeutics, Inc.

Holdings reported by Ralph Niven for Aerovate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 41.7K $563K $13.49 Feb 5, 2024 Direct Common Stock
Common Stock 1.61K $28.1K $17.45 Feb 5, 2024 Direct

Transactions reported by Ralph Niven for Aerovate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.